Delivery Order 75N91022D00006-75N91023F00004

Award Date 9/1/23
Potential Completion Date 8/31/29
Potential Value $21M
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $32,485,777.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a prominent professional services firm. The contract supports the Infections and Immunoepidemiology Branch (IIB) and Integrative Tumor Epidemiology Branch (ITEB) of the NCI's Division of Cancer Epidemiology and Genetics (DCEG) with field and biospecimen support services. This work is being conducted under the DCEG Field and Biospecimen Support Services indefinite...
This is a $19,307,275.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a professional services firm headquartered in Rockville, Maryland. The contract is for occupational and environmental epidemiology support services to the NCI's Occupational and Environmental Epidemiology Branch (OEEB), with a period of performance through September 2030. The contract is a task order issued under the NCI's Division of Cancer Epidemiology and...
This is a $15,339,013.00 cost-plus-fixed-fee delivery order awarded to Westat, Inc. by the National Cancer Institute (NCI). The task order provides technical support services to the NCI's Division of Cancer Epidemiology and Genetics (DCEG) Metabolic Epidemiology Branch in accordance with the statement of work. The award is part of the DCEG Field and Biospecimen Support Services IDIQ contract vehicle. No set-aside was used for this award. Westat is a prominent professional services firm that...
This is a $65,127,025.00 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a professional services firm. The contract is for clinical genetics branch support services, including services such as site study setup, protocol writing, and electronic patient-reported outcomes collection for cancer clinical trials. Westat has extensive experience providing research, technical assistance, and program support services to federal agencies,...
This is a $16,784,848.00 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The contract is for support services related to studies of infection, immunity, and cancer, and has a period of performance through July 5, 2024. Westat has extensive experience supporting federal agencies, including the NCI, across a range of public health, research,...
This federal contract award, valued at $41,827,930.94, was issued by the National Cancer Institute (NCI) to Westat, Inc., a prominent professional services firm based in Rockville, Maryland. The contract, which has no set-aside designation, is for the "DEVELOPMENT AND TECHNICAL SERVICES FOR THE NCI APPLIED RESEARCH PROGRAM" and has an ultimate completion date of August 31, 2014. Westat has extensive experience providing research, technical assistance, and program support services to...
This is a federal contract award to Westat, Inc., a professional services firm, by the National Cancer Institute (NCI), a civilian agency under the Department of Health and Human Services. The $10,071,871.00 cost-plus-fixed-fee contract is for biomedical (applied/exploratory) services and has a completion date of September 29, 2005. The contract is not set aside. Westat has extensive experience providing research, technical assistance, and program support services to various federal agencies,...
This is a $16,483,606.00 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a prominent professional services firm. The contract is for support services related to integrative epidemiological studies, with a period of performance through March 21, 2024. Westat has extensive experience working with federal agencies, including the NCI, on a variety of research, data collection, and program evaluation initiatives across public health, medical,...
This is a $20,707,528.00 definitive, cost-plus-fixed-fee contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Westat, Inc., a for-profit professional services provider. The contract is for support services to conduct a wide variety of domestic and international family studies and field studies related to clinical cancer genetics. The work includes research nurse, genetic counselor, and research assistant support, as well as...
This is a $124,999.70 firm-fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a prominent professional services firm. The contract is for a 12-month period of performance related to a task order under a larger NCI indefinite-delivery/indefinite-quantity (IDIQ) contract for field and biospecimen support services. Westat has also been awarded several other major IDIQ contracts with NCI and other agencies, indicating its extensive experience...

This is a $21,248,975.00 cost-plus-fixed-fee delivery order contract awarded to Westat, Inc., a professional services firm in Rockville, Maryland, by the National Cancer Institute (NCI). The contract provides clinical, genetic, and epidemiological support services under the Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The contract does not have a small business set-aside designation. Westat, a for-profit organization, will provide research, technical assistance, program support, data collection, analysis, and evaluation services to support NCI's public health and scientific research efforts through August 31, 2029.

Generated 7/1/25, 2:45 PM